Design of novel nicotinamides as potent and selective monoamine oxidase a inhibitors

被引:18
|
作者
Shi, Lei [1 ]
Yang, Ying [1 ]
Li, Zi-Lin [1 ]
Zhu, Zhen-Wei [1 ]
Liu, Chang-Hong [1 ]
Zhu, Hai-Liang [1 ]
机构
[1] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Peoples R China
基金
美国国家科学基金会;
关键词
Monoamine oxidase; Inhibitors; Nicotinamides; Structure-activity relationship; Molecular docking; CRYSTAL-STRUCTURES; DRUG TARGET; MAO-B; BRAIN; ANTIDEPRESSANTS; POPULATIONS; DISEASE; BINDING;
D O I
10.1016/j.bmc.2009.12.065
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of N-(2-morpholinoethyl)nicotinamide (1-13) and N-(3-morpholinopropyl)nicotinamide derivatives (14-26) have been designed, synthesized and evaluated in vitro for their monoamine oxidase (MAO) A and B inhibitory activity and selectivity. Most of these synthesized compounds proved to be potent, and selective inhibitors of MAO-A rather than of MAO-B. 5-Chloro-6-hydroxy-N-(2-morpholinoethyl)nicotinamide (13) displayed the highest MAO-A inhibitory potency (IC50 = 0.045 mu M) and a good selectivity. 2-Bromo-N-(2-morpholinoethyl)nicotinamide (3) was the most potent MAO-B inhibitor with the IC50 value of 0.32 mu M, but it was not selective. Molecular dockings of compound 13 were performed in order to give structural insights regarding the MAO-A selectivity. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1659 / 1664
页数:6
相关论文
共 50 条
  • [31] DESIGN AND EARLY CLINICAL-EVALUATION OF SELECTIVE INHIBITORS OF MONOAMINE-OXIDASE
    PALFREYMAN, MG
    MCDONALD, IA
    BEY, P
    SCHECHTER, PJ
    SJOERDSMA, A
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1988, 12 (06): : 967 - 987
  • [32] Combined 3D-QSAR and docking analysis for the design and synthesis of chalcones as potent and selective monoamine oxidase B inhibitors
    Mellado, Marco
    Gonzalez, Cesar
    Mella, Jaime
    Aguilar, Luis F.
    Vina, Dolores
    Uriarte, Eugenio
    Cuellar, Mauricio
    Matos, Maria J.
    BIOORGANIC CHEMISTRY, 2021, 108
  • [33] SELECTIVE AND NON-SELECTIVE MONOAMINE-OXIDASE INHIBITORS
    PICKAR, D
    MURPHY, DL
    COHEN, RM
    CAMPBELL, IC
    LIPPER, S
    ARCHIVES OF GENERAL PSYCHIATRY, 1982, 39 (05) : 535 - 540
  • [34] The discovery of 6-amino nicotinamides as potent and selective histone deacetylase inhibitors
    Hamblett, Christopher L.
    Methot, Joey L.
    Mampreian, Dawn M.
    Sloman, David L.
    Stanton, Matthew G.
    Kral, Astrid M.
    Fleming, Judith C.
    Cruz, Jonathan C.
    Chenard, Melissa
    Ozerova, Nicole
    Hitz, Anna M.
    Wang, Hongmei
    Deshmukh, Sujal V.
    Nazef, Nalm
    Harsch, Andreas
    Hughes, Bethany
    Dahlberg, William K.
    Szewczak, Alex A.
    Middleton, Richard E.
    Mosley, Ralph T.
    Secrist, J. Paul
    Miller, Thomas A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (19) : 5300 - 5309
  • [35] Computational Exploration of Xanthones Derivatives as Potent Inhibitors of Monoamine Oxidase
    El Masaoudy, Yassine
    Alaqarbeh, Marwa
    Maghat, Hamid
    Lakhlifi, Tahar
    Bouachrine, Mohammed
    JORDAN JOURNAL OF CHEMISTRY, 2024, 19 (02) : 107 - 123
  • [36] N-CYCLOPROPYLTRYPTAMINES, POTENT MONOAMINE-OXIDASE INHIBITORS
    WINN, M
    HORROM, BW
    RASMUSSEN, RR
    CHAPPELL, EB
    PLOTNIKOFF, NP
    JOURNAL OF MEDICINAL CHEMISTRY, 1975, 18 (04) : 437 - 438
  • [37] Isatoic anhydrides as novel inhibitors of monoamine oxidase
    Hitge, Rialette
    Petzer, Anel
    Petzer, Jacobus P.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2022, 73
  • [38] STUDIES OF SELECTIVE AND REVERSIBLE MONOAMINE-OXIDASE INHIBITORS
    MANN, JJ
    AARONS, SF
    FRANCES, AJ
    BROWN, RD
    JOURNAL OF CLINICAL PSYCHIATRY, 1984, 45 (07) : 62 - 66
  • [39] Synthesis and evaluation of small molecules bearing a benzyloxy substituent as novel and potent monoamine oxidase inhibitors
    Lan, Jin-Shuai
    Zhang, Tong
    Liu, Yun
    Zhang, Yong
    Hou, Jian-wei
    Xie, Sai-Sai
    Yang, Jing
    Ding, Yue
    Cai, Zhen-zhen
    MEDCHEMCOMM, 2017, 8 (02) : 471 - 478
  • [40] Synthesis of novel thiazolyl hydrazone derivatives as potent dual monoamine oxidase-aromatase inhibitors
    Evren, Asaf Evrim
    Nuha, Demokrat
    Dawbaa, Sam
    Saglik, Begum Nurpelin
    Yurttas, Leyla
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 229